Status:

COMPLETED

Safety and Effectiveness of Soy Phytoestrogens to Prevent Bone Loss

Lead Sponsor:

Baylor College of Medicine

Collaborating Sponsors:

University of California

Kaiser Foundation Research Institute

Conditions:

Osteoporosis

Eligibility:

FEMALE

40-60 years

Phase:

NA

Brief Summary

The purpose of this study is to determine whether soy isoflavone supplementation is safe and effective to prevent bone loss in postmenopausal women.

Detailed Description

Over-the-counter soy isoflavone supplement usage is becoming common among postmenopausal women. However, there is no documented scientific evidence of its long-term safety and efficacy in preventing o...

Eligibility Criteria

Inclusion

  • Must be able to swallow the pills
  • No menses for 12 months
  • Blood follicle stimulating hormone great than 30 IU/mL
  • Lumbar spine bone mineral density t-score equal to or greater than -1.5

Exclusion

  • Strict vegetarians
  • Current or recent smokers (within last five years)
  • Abnormal screening mammogram, Pap smear and blood chemistries
  • Clinical diagnosis of osteoporosis, spine and/or hip fracture, cancer, liver, kidney, gallbladder and heart disease
  • Clinical diagnosis of psychiatric disorder
  • Any allergic reactions to soy products
  • Current treatment with bisphosphonates, calcitonin, fluoride, corticosteroids, tamoxifen, raloxifene, HRT, premarin, farestron and letrozole
  • Current usage of black cohosh, blue cohosh, dong quai, Caltrate 600+Soy, Estroven, ginseng, Healthy Women, Natural Estrogen, Opti-Soy, PhytoFem, Probalance, Promensil, Remifemin, Rimostil and Trinovin

Key Trial Info

Start Date :

April 1 2001

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2006

Estimated Enrollment :

403 Patients enrolled

Trial Details

Trial ID

NCT00665860

Start Date

April 1 2001

End Date

June 1 2006

Last Update

November 27 2020

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

University of California

Davis, California, United States, 95616

2

University of Georgia

Athens, Georgia, United States, 30602

3

Baylor College of Medicine

Houston, Texas, United States, 77030